We have previously shown that in the prostate cancer cell line LNCaP a low number of Orai3 subunits within store-operated CRAC channels alters the 2-APB response compared to Orai1-mediated currents when 50 μM was applied [18]. Here, ORAI3 is linked to prostate cancer.